Biora Therapeuti – Filings and Transcripts – BamSEC

You must log in to view this page.

You must log in to view this page.

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Removal from listing

Prospectus supplement for primary offering

Prospectus supplement

Prospectus supplement

Prospectus supplement

Ownership Filter

Taggett Margaret Ellen

Davidson Kempner Capital Management LP

Context Capital Management, LLC

Athyrium Opportunities III Co-Invest 1 LP

Ferrell Jeffrey, Athyrium Opportunities Associates III GP LLC, Athyrium Funds GP Holdings LLC, Athyrium Opportunities Associates Co-Invest LLC, Athyrium Opportunities III Co-Invest 1 LP, Athyrium Opportunities 2020 LP, Athyrium Opportunities Associates III LP, Athyrium Opportunities III Acquisition 2 LP, Athyrium Opportunities III Acquisition LP

News Filter

Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC